Nuvectis Pharma (NVCT) Insider Trading & Ownership

$6.51
-0.20 (-2.98%)
(As of 04/25/2024 ET)

Nuvectis Pharma (NASDAQ:NVCT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
38.85%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$3.08 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get NVCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NVCT Insider Buying and Selling by Quarter

Nuvectis Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2024Ron BentsurCEOBuy5,000$10.29$51,450.00  
10/9/2023Ron BentsurCEOBuy830$11.19$9,287.70  
10/6/2023Ron BentsurCEOBuy250$11.27$2,817.50  
10/4/2023Ron BentsurCEOBuy1,820$10.95$19,929.00  
8/15/2023Ron BentsurCEOBuy235$14.34$3,369.90  
8/11/2023Ron BentsurCEOBuy180$14.66$2,638.80  
8/8/2023Ron BentsurCEOBuy120$14.83$1,779.60  
7/31/2023Marlio Charles MosseriMajor ShareholderBuy860$13.88$11,936.80  
7/28/2023Marlio Charles MosseriMajor ShareholderBuy2,584$13.91$35,943.44  
7/26/2023Marlio Charles MosseriMajor ShareholderBuy10,000$13.97$139,700.00  
7/21/2023Ron BentsurCEOBuy225$14.85$3,341.25  
7/20/2023Marlio Charles MosseriMajor ShareholderBuy5,394$14.40$77,673.60  
7/19/2023Ron BentsurCEOBuy200$14.33$2,866.00  
7/18/2023Marlio Charles MosseriMajor ShareholderBuy9,149$14.84$135,771.16  
7/14/2023Ron BentsurCEOBuy150$15.03$2,254.50  
7/11/2023Marlio Charles MosseriMajor ShareholderBuy10,000$15.36$153,600.00  
7/7/2023Marlio Charles MosseriMajor ShareholderBuy8,948$15.19$135,920.12  
7/6/2023Ron BentsurCEOBuy320$14.88$4,761.60  
7/5/2023Marlio Charles MosseriMajor ShareholderBuy1,176$15.52$18,251.52  
6/26/2023Marlio Charles MosseriMajor ShareholderBuy16,760$16.46$275,869.60  
6/26/2023Ron BentsurCEOBuy750$16.50$12,375.00  
6/23/2023Marlio Charles MosseriMajor ShareholderBuy73,175$17.43$1,275,440.25  
6/21/2023Marlio Charles MosseriMajor ShareholderBuy6,091$17.71$107,871.61  
6/21/2023Ron BentsurCEOBuy500$17.88$8,940.00  
6/15/2023Marlio Charles MosseriMajor ShareholderBuy32,124$17.71$568,916.04  
6/7/2023Ron BentsurCEOBuy230$17.41$4,004.30  
5/31/2023Ron BentsurCEOBuy330$17.28$5,702.40  
5/24/2023Ron BentsurCEOBuy200$17.49$3,498.00  
5/16/2023Ron BentsurCEOBuy320$17.02$5,446.40  
(Data available from 1/1/2013 forward)

NVCT Insider Trading Activity - Frequently Asked Questions

Who is on Nuvectis Pharma's Insider Roster?

The list of insiders at Nuvectis Pharma includes Enrique Poradosu, Kenneth Hoberman, Marlio Charles Mosseri, Ron Bentsur, and Shay Shemesh. Learn more on insiders at NVCT.

What percentage of Nuvectis Pharma stock is owned by insiders?

38.85% of Nuvectis Pharma stock is owned by insiders. Learn more on NVCT's insider holdings.

Which Nuvectis Pharma insiders have been buying company stock?

The following insiders have purchased NVCT shares in the last 24 months: Enrique Poradosu ($5,775.00), Kenneth Hoberman ($208,800.00), Marlio Charles Mosseri ($2,936,894.14), Ron Bentsur ($799,409.98), and Shay Shemesh ($45,979.20).

How much insider buying is happening at Nuvectis Pharma?

Insiders have purchased a total of 263,489 NVCT shares in the last 24 months for a total of $3,996,858.32 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:NVCT) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners